InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the complete record of transactions filed by Tsai Benjamin, Director. Officer active across 2 companies, notably Oyster Point Pharma, Inc.. Aggregated, 3 reports have been logged. Activity tracked since 7 June 2021. The latest transaction was filed on 6 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Tsai Benjamin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
10,066 sharesCommon StockSEC:0001209191-23-001095:0
3,573 shares0Common StockSEC:0001209191-22-035061:0
3,466 shares0Common StockSEC:0001209191-21-039338:0
3 of 3 declarations
About Tsai Benjamin
Benjamin Tsai is a Board Member at Oyster Point Pharma, Inc. He plays a key role in overseeing the company's activities and strategic direction. His experience in the pharmaceutical sector allows him to provide valuable insights to the board.
